PL373140A1 - Polimorficzne formy znanych estrów dodekahydocyklopenta (A) fenantrylowych kwasu tiofenokarboksylowego - Google Patents

Polimorficzne formy znanych estrów dodekahydocyklopenta (A) fenantrylowych kwasu tiofenokarboksylowego

Info

Publication number
PL373140A1
PL373140A1 PL03373140A PL37314003A PL373140A1 PL 373140 A1 PL373140 A1 PL 373140A1 PL 03373140 A PL03373140 A PL 03373140A PL 37314003 A PL37314003 A PL 37314003A PL 373140 A1 PL373140 A1 PL 373140A1
Authority
PL
Poland
Prior art keywords
dodecahydrocyclopenta
polymorphis
thiophenecarboxylic acid
phenanthrenyl ester
phenanthrenyl
Prior art date
Application number
PL03373140A
Other languages
English (en)
Other versions
PL209409B1 (pl
Inventor
Guido Jordine
Michael Mutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL373140A1 publication Critical patent/PL373140A1/pl
Publication of PL209409B1 publication Critical patent/PL209409B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL373140A 2002-07-29 2003-07-28 Polimorficzna forma B estru dodekahydrocyklopenta(a)fenantrylowego kwasu tiofenokarboksylowego, kompozycja farmaceutyczna zawierająca tę formę polimorficzną, zastosowanie tej formy polimorficznej oraz sposób jej wytwarzania PL209409B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0217504.0A GB0217504D0 (en) 2002-07-29 2002-07-29 Organic compounds

Publications (2)

Publication Number Publication Date
PL373140A1 true PL373140A1 (pl) 2005-08-22
PL209409B1 PL209409B1 (pl) 2011-08-31

Family

ID=9941275

Family Applications (1)

Application Number Title Priority Date Filing Date
PL373140A PL209409B1 (pl) 2002-07-29 2003-07-28 Polimorficzna forma B estru dodekahydrocyklopenta(a)fenantrylowego kwasu tiofenokarboksylowego, kompozycja farmaceutyczna zawierająca tę formę polimorficzną, zastosowanie tej formy polimorficznej oraz sposób jej wytwarzania

Country Status (30)

Country Link
US (1) US7683048B2 (pl)
EP (2) EP1676854A1 (pl)
JP (1) JP2006501207A (pl)
KR (1) KR100688371B1 (pl)
CN (1) CN1305892C (pl)
AR (1) AR040692A1 (pl)
AT (1) ATE349459T1 (pl)
AU (1) AU2003251651B2 (pl)
BR (1) BR0313044A (pl)
CA (1) CA2493330C (pl)
CY (1) CY1106406T1 (pl)
DE (1) DE60310747T2 (pl)
DK (1) DK1554303T3 (pl)
EC (1) ECSP055579A (pl)
ES (1) ES2279970T3 (pl)
GB (1) GB0217504D0 (pl)
HK (1) HK1080484B (pl)
IL (2) IL166287A0 (pl)
MX (1) MXPA05001173A (pl)
MY (1) MY136407A (pl)
NO (1) NO20050806L (pl)
NZ (2) NZ537868A (pl)
PE (1) PE20040722A1 (pl)
PL (1) PL209409B1 (pl)
PT (1) PT1554303E (pl)
RU (2) RU2348646C1 (pl)
SI (1) SI1554303T1 (pl)
TW (1) TWI309164B (pl)
WO (1) WO2004013156A1 (pl)
ZA (1) ZA200500370B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
PT1305329E (pt) 2000-08-05 2007-12-24 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-(2-furanilcarboxil)oxi-11.beta.-hidroxi-16.alfa.-metil- 3-oxo-androsta-1,4-dieno-17-carbotióico como um agente antiinflamatório
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
MY137522A (en) 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU550939A1 (ru) * 1975-05-19 1994-07-15 Институт химии древесины АН ЛатвССР 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли
JPH08291073A (ja) * 1995-04-22 1996-11-05 Kissei Pharmaceut Co Ltd 医薬品組成物及びその製造方法
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1554303A1 (en) 2005-07-20
HK1080484A1 (en) 2006-04-28
RU2348646C1 (ru) 2009-03-10
NO20050806L (no) 2005-02-15
GB0217504D0 (en) 2002-09-04
EP1676854A1 (en) 2006-07-05
SI1554303T1 (sl) 2007-06-30
TW200401633A (en) 2004-02-01
HK1080484B (en) 2007-08-03
CY1106406T1 (el) 2011-10-12
PE20040722A1 (es) 2004-11-29
MXPA05001173A (es) 2005-05-16
ECSP055579A (es) 2005-04-18
AU2003251651B2 (en) 2007-07-12
CN1671731A (zh) 2005-09-21
ZA200500370B (en) 2006-07-26
ES2279970T3 (es) 2007-09-01
DE60310747T2 (de) 2007-10-11
BR0313044A (pt) 2005-06-14
DK1554303T3 (da) 2007-04-30
US20060166954A1 (en) 2006-07-27
CA2493330C (en) 2011-08-23
RU2330043C2 (ru) 2008-07-27
RU2005105688A (ru) 2005-10-10
KR20050033632A (ko) 2005-04-12
KR100688371B1 (ko) 2007-03-02
CN1305892C (zh) 2007-03-21
EP1554303B1 (en) 2006-12-27
JP2006501207A (ja) 2006-01-12
RU2007143025A (ru) 2009-01-20
AU2003251651A1 (en) 2004-02-23
TWI309164B (en) 2009-05-01
NZ537868A (en) 2006-11-30
PL209409B1 (pl) 2011-08-31
IL184848A0 (en) 2007-12-03
DE60310747D1 (en) 2007-02-08
NZ549713A (en) 2008-04-30
CA2493330A1 (en) 2004-02-12
IL166287A0 (en) 2006-01-15
MY136407A (en) 2008-09-30
US7683048B2 (en) 2010-03-23
WO2004013156A1 (en) 2004-02-12
ATE349459T1 (de) 2007-01-15
PT1554303E (pt) 2007-03-30
AR040692A1 (es) 2005-04-13

Similar Documents

Publication Publication Date Title
IL184848A0 (en) Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester
GB0311218D0 (en) Dynamic configuration of a gaming system
GB2430532B (en) System for electronic game promotion
ZA200408643B (en) System for playing a game
AU2002253999A1 (en) Ascorbic acid analogs for metalloradiopharmaceuticals
ZA200500338B (en) Method of conducting a wagering game
AU2003225651A8 (en) Nematicidal fatty acid and fatty acid ester related compounds
GB2393785B (en) Method of making a free standing structure
GB0220740D0 (en) Administration of a system
GB0230240D0 (en) Removal of an acid
EP1425258A4 (en) ANALOGUES OF HYDROXYEICOSENOIC ACID
IL164773A0 (en) Ester derivatives of a decahydroisoquinoline-3-carboxlic acid as analgesics
SG107315A1 (en) Use of conjugated linoleic acid derivatives
AU2003230064A1 (en) Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
AU2003258716A8 (en) Tocopheryl ester
AU2003295573A1 (en) Modular lance
GB0229288D0 (en) A modification of chess
AU2003226547A1 (en) Improved form of competition
GB0416893D0 (en) A method of operating a sensor
AU154371S (en) A set of single cards
AU150580S (en) A set of single cards
GB0209145D0 (en) A set of steps
GB0214374D0 (en) A method of sputtering
AU2002951719A0 (en) A method of providing rewards to leasees
TJ20010651A (en) A method of game ikhlos

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140728